JPRN-UMIN000025776已完成未知
Predictors for therapeutic effect of Lusutrombopag in chronic liver disease - Predictors of Lusutrombopag
Kitasato University School of Medicine0 个研究点目标入组 50 人开始时间: 2017年1月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with a hematologic malignancy. 2.Active malignancy at time of study entry except HCC. 3.Patients who underwent liver transplantation 4.Patients with a severe liver dysfunction (Child-pugh C) 5.Patients with a medical history of thrombosis. 6.Patients with a medical history of thrombotic disease adult patients. 7.Women who are pregnant or breastfeeding 8.Severe GI bleeding. 9.Not appropriate for this study
研究者
相似试验
招募中
1 期
Study to evaluate the effect of Luspatercept on transfusion independence of red blood cells (lack of transfusions for 8 consecutive weeks within the first 24 weeks) in subjects with MDS with del (5q) with very low risk, low risk, intermediatedel IPSS-R index and and <5% blasts, resistant / refractory / intolerant to Lenalidomide and dependent on red blood cell transfusions.Anemia due to MDS with del5q with IPSS-R very low, low, or intermediate risk MDS and a bone marrow blast count of < 5% , Refractory or intolerant to, or ineligible for, prior ESA treatment and for prior lenalidomide treatment and who require RBC transfusions.MedDRA version: 20.0Level: LLTClassification code 10028532Term: MyelodysplasiaSystem Organ Class: 100000004864EUCTR2021-001538-20-ITASSOCIAZIONE QOL-ONE22
已完成
不适用
Comparison between Lusutrombopag and effectiveness of the platelet blood transfusioThrombopeniaJPRN-UMIN000032777Tokyo Medical University80
已完成
不适用
Prediction of therapeutic effect for refractory ulcerative colitis by measuring cytokines in colon lesion tissue and bloodulcerative colitisJPRN-UMIN000005699Keio University, School of Medicine Department of Internal Medicine Division of Gastroenterology and Hepatology60
已完成
3 期
Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive ProceduresChronic Liver DiseaseThrombocytopeniaNCT02389621Shionogi215
已完成
2 期
Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP)Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraNCT06287567Institute of Hematology & Blood Diseases Hospital, China17